Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 177.87%2.97B | 2.58%1.59B | 53.37%1.44B | 120.43%1.33B | 159.33%1.07B | 104.74%1.55B | 37.15%940.08M | 3.78%605.25M | -6.43%412.78M | -35.35%754.91M |
Operating revenue | 177.87%2.97B | 2.58%1.59B | 53.37%1.44B | 120.43%1.33B | 159.33%1.07B | 104.74%1.55B | 37.15%940.08M | 3.78%605.25M | -6.43%412.78M | -35.35%754.91M |
Other operating revenue | ---- | -41.89%2.16M | ---- | 1,790.26%18.07M | ---- | -12.58%3.72M | ---- | -97.13%955.94K | ---- | -80.49%4.25M |
Total operating cost | 16.39%671.65M | 6.44%1.1B | 39.61%896.95M | 88.77%787.58M | 78.84%577.08M | 46.61%1.03B | 5.70%642.48M | -3.89%417.22M | -6.50%322.68M | -9.37%704.4M |
Operating cost | 16.38%644.91M | 6.30%987.59M | 36.57%822.34M | 89.05%741.68M | 79.67%554.13M | 52.13%929.05M | 7.51%602.14M | -2.39%392.32M | -6.30%308.41M | -15.27%610.69M |
Operating tax surcharges | 456.23%2.41M | 42.68%2.64M | 30.83%1.8M | 93.41%1.51M | 58.55%433.05K | 12.88%1.85M | 44.32%1.38M | 23.80%778.44K | -9.43%273.13K | -42.34%1.64M |
Operating expense | 14.61%817.88K | -43.57%2.79M | -26.10%2.42M | 23.56%1.72M | 29.34%713.6K | -16.77%4.94M | -22.22%3.28M | -55.72%1.39M | -70.00%551.74K | -39.47%5.94M |
Administration expense | -22.42%18.16M | -6.07%100.59M | 42.22%71.35M | 43.94%47.52M | 43.69%23.41M | 15.49%107.08M | 4.79%50.17M | 3.02%33.01M | 9.92%16.29M | 38.19%92.72M |
Financial expense | 63.83%-3.61M | 34.91%-27.36M | 28.34%-21.09M | 11.81%-17.55M | -23.81%-9.99M | -66.36%-42.04M | -57.01%-29.43M | -59.25%-19.9M | -52.17%-8.07M | 40.20%-25.27M |
-Interest expense (Financial expense) | -13.19%806.03K | -14.08%3.58M | -6.89%2.74M | -15.90%1.85M | -34.36%928.5K | 16.57%4.17M | 6.92%2.94M | 17.16%2.2M | 55.85%1.41M | -10.96%3.58M |
-Interest Income (Financial expense) | 59.95%-4.36M | 32.20%-31.3M | 25.21%-24.12M | 11.10%-19.47M | -17.75%-10.88M | -59.45%-46.16M | -51.28%-32.25M | -53.76%-21.9M | -48.85%-9.24M | 37.17%-28.95M |
Research and development | 6.86%8.97M | 3.67%33M | 34.67%20.13M | 32.16%12.7M | 60.57%8.39M | 70.30%31.83M | 11.21%14.95M | 8.90%9.61M | 22.00%5.22M | -1.63%18.69M |
Credit Impairment Loss | -45.76%-24.91M | -18.36%-87.76M | 114.43%2.52M | 108.08%1.19M | -27.47%-17.09M | -237.42%-74.14M | -156.04%-17.44M | -149.63%-14.77M | -213.93%-13.41M | -177.51%-21.97M |
Asset Impairment Loss | ---- | 26.21%-29.85M | ---- | ---- | ---- | 94.37%-40.46M | ---- | ---- | ---- | -49.48%-719.19M |
Other net revenue | 1,917.83%48.02M | -480.79%-126.92M | -76.75%27.65M | -28.54%33.51M | -95.02%2.38M | 97.19%-21.85M | 330.24%118.97M | -29.67%46.9M | 458.55%47.81M | -17.22%-778.3M |
Fair value change income | 484.08%3.14M | 500.06%13.66M | 3,598.19%8.47M | 1,356.09%3.04M | --537.53K | -39.83%2.28M | -104.33%-242.07K | -130.47%-242.07K | ---- | -71.06%3.78M |
Invest income | 564.87%60.14M | -194.55%-58.1M | -107.86%-9.14M | -68.24%15.3M | -84.37%9.05M | 192.37%61.45M | 694.53%116.3M | 83.25%48.18M | 268.30%57.89M | 75.69%-66.53M |
-Including: Investment income associates | 495.44%53.45M | -205.59%-62.33M | -111.47%-13.19M | -69.30%14.37M | -84.47%8.98M | 167.43%59.03M | 360.90%114.93M | 1,382.54%46.81M | 232.99%57.82M | 70.42%-87.55M |
Asset deal income | --355.46 | ---- | ---- | ---- | ---- | ---135.6K | ---- | ---- | ---- | ---- |
Other revenue | -2.47%9.64M | 20.52%35.14M | 26.86%25.81M | 1.81%13.98M | 197.50%9.88M | 13.83%29.15M | 93.63%20.34M | 39.61%13.73M | -39.43%3.32M | -48.12%25.61M |
Operating profit | 374.19%2.35B | -26.81%359.4M | 37.43%572.49M | 146.91%580.06M | 259.50%495.77M | 167.47%491.07M | 295.78%416.56M | 8.87%234.93M | 66.75%137.91M | -166.07%-727.79M |
Add:Non operating Income | 147.28%434.84K | 9.48%2.57M | 11.89%1.92M | -59.34%510.44K | -68.77%175.85K | -43.90%2.34M | -47.65%1.72M | -36.30%1.26M | -40.92%563.05K | -83.89%4.18M |
Less:Non operating expense | 65,654.45%1.01M | 181.41%3.85M | 13,065.52%3.81M | 12,946.81%3.77M | -80.83%1.54K | 33.44%1.37M | -97.18%28.91K | 12.40%28.91K | -97.51%8.05K | 247.75%1.03M |
Total profit | 373.91%2.35B | -27.22%358.11M | 36.43%570.6M | 144.24%576.8M | 258.18%495.94M | 167.90%492.04M | 289.06%418.25M | 8.47%236.16M | 66.16%138.46M | -192.34%-724.64M |
Less:Income tax cost | 373.69%335.27M | -8.24%66.79M | 116.20%109.71M | 205.29%103.57M | 323.07%70.78M | 6,894.26%72.79M | 637.25%50.75M | 86.84%33.93M | 81.55%16.73M | -101.61%-1.07M |
Net profit | 373.94%2.02B | -30.51%291.32M | 25.41%460.89M | 134.00%473.23M | 249.27%425.17M | 157.94%419.25M | 265.24%367.5M | 1.33%202.23M | 64.25%121.73M | -130.14%-723.56M |
Net profit from continuing operation | 373.94%2.02B | -30.51%291.32M | 25.41%460.89M | 134.00%473.23M | 249.27%425.17M | 157.94%419.25M | 265.24%367.5M | 1.33%202.23M | 64.25%121.73M | -130.14%-723.56M |
Less:Minority Profit | -220.83%-725.71K | -148.12%-694.09K | 101.03%9.96K | 183.86%462.41K | 325.02%600.62K | 113.28%1.44M | 19.22%-968.6K | 42.81%-551.41K | 51.82%-266.92K | -298.95%-10.86M |
Net profit of parent company owners | 374.79%2.02B | -30.11%292.02M | 25.08%460.88M | 133.14%472.77M | 248.01%424.57M | 158.62%417.81M | 261.89%368.47M | 1.12%202.78M | 63.38%122M | -128.66%-712.71M |
Earning per share | ||||||||||
Basic earning per share | 360.00%0.69 | -28.57%0.1 | 23.08%0.16 | 128.57%0.16 | 275.00%0.15 | 158.33%0.14 | 333.33%0.13 | 0.00%0.07 | 33.33%0.04 | -118.18%-0.24 |
Diluted earning per share | 360.00%0.69 | -28.57%0.1 | 23.08%0.16 | 128.57%0.16 | 275.00%0.15 | 158.33%0.14 | 333.33%0.13 | 0.00%0.07 | 33.33%0.04 | -118.18%-0.24 |
Other composite income | 118.97%4.58M | -122.15%-29.41M | -371.89%-45.99M | -202.38%-41.71M | -235.91%-24.15M | -18.20%132.73M | 9,991.83%16.92M | 2,704.64%40.74M | 196.77%17.77M | 121.44%162.27M |
Other composite income of parent company owners | 118.97%4.58M | -122.15%-29.41M | -371.89%-45.99M | -202.38%-41.71M | -235.91%-24.15M | -18.20%132.73M | 9,991.83%16.92M | 2,704.64%40.74M | 196.77%17.77M | 121.44%162.27M |
Total composite income | 403.62%2.02B | -52.55%261.92M | 7.93%414.9M | 77.60%431.52M | 187.48%401.02M | 198.34%551.99M | 281.42%384.42M | 22.71%242.97M | 150.19%139.5M | -132.78%-561.29M |
Total composite income of parent company owners | 404.56%2.02B | -52.30%262.61M | 7.65%414.89M | 77.01%431.06M | 186.50%400.42M | 200.02%550.54M | 277.88%385.38M | 22.39%243.52M | 148.21%139.76M | -130.89%-550.44M |
Total composite income of minority owners | -220.83%-725.71K | -148.12%-694.09K | 101.03%9.96K | 183.86%462.41K | 325.02%600.62K | 113.28%1.44M | 19.22%-968.6K | 42.81%-551.41K | 51.82%-266.92K | -298.95%-10.86M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.